{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:19:01Z","timestamp":1792595941702,"version":"4.5.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamaneurol.2019.0765","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T15:32:24Z","timestamp":1555947144000},"page":"791","source":"Crossref","is-referenced-by-count":689,"title":["Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease"],"prefix":"10.1001","volume":"76","author":[{"given":"Niklas","family":"Mattsson","sequence":"first","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden"},{"name":"Department of Neurology, Sk\u00e5ne University Hospital, Sweden"},{"name":"Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Cullen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, United Kingdom"},{"name":"UK Dementia Research Institute at University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10043","key":"noi190019r1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease.","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"noi190019r2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jalz.2015.05.002","article-title":"Magnetic resonance imaging in Alzheimer\u2019s Disease Neuroimaging Initiative 2.","volume":"11","author":"Jack","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"11","key":"noi190019r3","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.jalz.2018.06.2855","article-title":"Molecular imaging in dementia: past, present, and future.","volume":"14","author":"Laforce","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi190019r4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-170773","article-title":"The past and the future of Alzheimer\u2019s disease fluid biomarkers.","volume":"62","author":"Blennow","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"noi190019r5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"noi190019r6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study.","volume":"3","author":"Gissl\u00e9n","year":"2015","journal-title":"EBioMedicine"},{"issue":"5","key":"noi190019r7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"issue":"4","key":"noi190019r8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"9596","key":"noi190019r10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"noi190019r11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization.","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"noi190019r12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"5","key":"noi190019r13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u00df-amyloid (1-42) in human cerebrospinal fluid.","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"11","key":"noi190019r14","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u00df PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts.","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"noi190019r15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/(ISSN)1522-2586","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods.","volume":"27","author":"Jack","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"pt 12","key":"noi190019r16","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1093\/brain\/awv283","article-title":"Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings.","volume":"138","author":"Jack","year":"2015","journal-title":"Brain"},{"key":"noi190019r17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-3-642-02498-6","article-title":"Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR.","volume":"21","author":"Schwarz","year":"2009","journal-title":"Inf Process Med Imaging"},{"issue":"4","key":"noi190019r18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline.","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"issue":"11","key":"noi190019r19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/ene.2017.24.issue-11","article-title":"Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.","volume":"24","author":"Kovacs","year":"2017","journal-title":"Eur J Neurol"},{"issue":"13","key":"noi190019r20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"noi190019r21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/ene.13554","article-title":"Serum neurofilament light chain in patients with acute cerebrovascular events.","volume":"25","author":"De Marchis","year":"2018","journal-title":"Eur J Neurol"},{"issue":"6","key":"noi190019r22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.v81.6","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis.","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"key":"noi190019r23","doi-asserted-by":"publisher","first-page":"36791","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"noi190019r24","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.3223","article-title":"Serum neurofilament light chain for prognosis of outcome after cardiac arrest.","author":"Moseby-Knappe","year":"2019","journal-title":"JAMA Neurol"},{"issue":"9","key":"noi190019r25","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.15252\/emmm.201707809","article-title":"18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer\u2019s disease.","volume":"9","author":"Mattsson","year":"2017","journal-title":"EMBO Mol Med"},{"key":"noi190019r9","unstructured":"Alzheimer Disease Neuroimaging Initiative. http:\/\/adni.loni.usc.edu. Accessed October 8, 2018."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/7\/791\/17684666\/jamaneurology_mattsson_2019_oi_190019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:00:49Z","timestamp":1562598049000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2019.0765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.0765","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}